Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …

Drug nanonization and encapsulation efficiency enhancement are prerequisites for
hydrophobic and hydrophilic drugs to be delivered at the targeted site. Microfluidic …

Background Process intensification is a major hurdle in pharmaceutical process scale-up.
Solvent removal strategies have limited the effectiveness of the overall stability of …

Glaucoma is related to the damaged optic nerve leading to the development of high
intraocular pressure. Currently, 12 million people in India suffer from glaucoma, making it the …

Cystic fibrosis (CF), a fatal genetic condition, causes thick, sticky mucus. It also causes
pancreatic dysfunction, bacterial infection, and increased salt loss. Currently available …

This study aims to develop and evaluate flurbiprofen-loaded polymeric nanoparticles to
achieve sustained drug release, enhancing therapeutic efficacy and minimising dosing …

Background Vildagliptin (VLG), an antidiabetic agent, presents a potential solution to this
widespread affliction. It exhibits notable attributes, such as a high solubility and a shorter …

Over the past decades, research on nanomedicines as innovative tools in combating
complex pathologies has increased tenfold, spanning fields from infectiology and …

Pulmonary drug delivery has long been used for local and systemic administration of
different medications used in acute and chronic respiratory diseases. Certain lung diseases …

In this review, an extensive analysis of dry powder inhalers (DPIs) is offered, focusing on
their characteristics, formulation, stability, and manufacturing. The advantages of pulmonary …